Table 5 Outcomes
From: Renal arteriography with endovascular ultrasound for the management of renal infarction patients
Follow up time (Months) | 59 ± 36 |
Current treatment | Number of patients (%) |
- None | 3 (12) |
- Anticoagulation therapy | 3 (12) |
- Antiplatelet therapy alone | 17 (68) |
- Both anticoagulation + antiplatelet therapies | 2 (8) |
Treatment change or discontinuation | 8 (32) |
MACCE | 0 (0) |
Death | 0 (0) |
Renal infarction recurrence | 0 (0) |
Bleeding | |
- BARC 0 | 13 (52) |
- BARC 1 | 9 (36) |
- BARC 2 | 2 (8) |
Creatinine level (μmol/L) /N = 18a | 93 ± 16 |
Renal insufficiency (eGFR < 60 mL/min) | 2 (8) |
End stage renal disease | 0 (0) |